AU2007251614B2 - Substituted prolinamides, production thereof and their use as drugs - Google Patents

Substituted prolinamides, production thereof and their use as drugs Download PDF

Info

Publication number
AU2007251614B2
AU2007251614B2 AU2007251614A AU2007251614A AU2007251614B2 AU 2007251614 B2 AU2007251614 B2 AU 2007251614B2 AU 2007251614 A AU2007251614 A AU 2007251614A AU 2007251614 A AU2007251614 A AU 2007251614A AU 2007251614 B2 AU2007251614 B2 AU 2007251614B2
Authority
AU
Australia
Prior art keywords
group
alkyl
denotes
groups
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007251614A
Other languages
English (en)
Other versions
AU2007251614A1 (en
Inventor
Georg Dahmann
Kai Gerlach
Herbert Nar
Roland Pfau
Henning Priepke
Annette Schuler-Metz
Wolfgang Wienen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2007251614A1 publication Critical patent/AU2007251614A1/en
Application granted granted Critical
Publication of AU2007251614B2 publication Critical patent/AU2007251614B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2007251614A 2006-05-16 2007-05-14 Substituted prolinamides, production thereof and their use as drugs Ceased AU2007251614B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06113977.0 2006-05-16
EP06113977 2006-05-16
EP07102566 2007-02-16
EP07102566.2 2007-02-16
PCT/EP2007/054631 WO2007131982A2 (de) 2006-05-16 2007-05-14 Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
AU2007251614A1 AU2007251614A1 (en) 2007-11-22
AU2007251614B2 true AU2007251614B2 (en) 2013-01-17

Family

ID=38646563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007251614A Ceased AU2007251614B2 (en) 2006-05-16 2007-05-14 Substituted prolinamides, production thereof and their use as drugs

Country Status (23)

Country Link
US (1) US7807693B2 (cg-RX-API-DMAC7.html)
EP (1) EP2051975B1 (cg-RX-API-DMAC7.html)
JP (1) JP5263686B2 (cg-RX-API-DMAC7.html)
KR (1) KR101422456B1 (cg-RX-API-DMAC7.html)
AR (1) AR060945A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007251614B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0711648A2 (cg-RX-API-DMAC7.html)
CA (1) CA2653753C (cg-RX-API-DMAC7.html)
CL (1) CL2007001391A1 (cg-RX-API-DMAC7.html)
DK (1) DK2051975T3 (cg-RX-API-DMAC7.html)
EA (1) EA200802210A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088824A (cg-RX-API-DMAC7.html)
ES (1) ES2395538T3 (cg-RX-API-DMAC7.html)
IL (1) IL195245A (cg-RX-API-DMAC7.html)
MX (1) MX2008014499A (cg-RX-API-DMAC7.html)
MY (1) MY146623A (cg-RX-API-DMAC7.html)
NO (1) NO20084530L (cg-RX-API-DMAC7.html)
NZ (1) NZ573573A (cg-RX-API-DMAC7.html)
PE (1) PE20080702A1 (cg-RX-API-DMAC7.html)
PL (1) PL2051975T3 (cg-RX-API-DMAC7.html)
TW (1) TW200813047A (cg-RX-API-DMAC7.html)
UY (1) UY30352A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007131982A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975165A1 (de) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
WO2009063028A2 (en) 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US20110046130A1 (en) * 2008-03-31 2011-02-24 Evotec Ag Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds
EP2958919B1 (en) 2013-02-21 2019-05-22 Boehringer Ingelheim International GmbH Dihydropteridinones i
JP6337750B2 (ja) * 2013-11-22 2018-06-06 小野薬品工業株式会社 化合物
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
HRP20221373T1 (hr) * 2014-03-07 2023-01-06 Biocryst Pharmaceuticals, Inc. Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN114646701B (zh) * 2022-03-01 2023-09-29 浙江国邦药业有限公司 一种l-脯氨酰胺中有关物质的hplc测试方法
CN121311466A (zh) * 2023-04-14 2026-01-09 辉瑞大药厂 葡萄糖依赖性促胰岛素多肽受体拮抗剂及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110433A1 (de) * 2003-06-18 2004-12-23 Merck Patent Gmbh Pyrrolidin-1, 2- dicarbonsäure- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
JP3975254B2 (ja) * 2002-07-25 2007-09-12 日野自動車株式会社 チャイルドシート用アンカの取付構造
PL377633A1 (pl) 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
DE10329457A1 (de) * 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
DE10358814A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh Prolinylarylacetamide
DE102004014945A1 (de) 2004-03-26 2005-10-13 Merck Patent Gmbh Prolinylderivate
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1869010A1 (en) 2005-04-11 2007-12-26 Glaxo Group Limited 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
AU2006271781A1 (en) * 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110433A1 (de) * 2003-06-18 2004-12-23 Merck Patent Gmbh Pyrrolidin-1, 2- dicarbonsäure- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen

Also Published As

Publication number Publication date
CA2653753C (en) 2013-09-24
PE20080702A1 (es) 2008-07-10
IL195245A (en) 2012-09-24
DK2051975T3 (da) 2012-10-15
JP5263686B2 (ja) 2013-08-14
WO2007131982A2 (de) 2007-11-22
US20080139605A1 (en) 2008-06-12
MY146623A (en) 2012-09-14
AU2007251614A1 (en) 2007-11-22
AR060945A1 (es) 2008-07-23
EP2051975B1 (de) 2012-09-12
EP2051975A2 (de) 2009-04-29
US7807693B2 (en) 2010-10-05
TW200813047A (en) 2008-03-16
KR101422456B1 (ko) 2014-07-23
CA2653753A1 (en) 2007-11-22
HK1131140A1 (en) 2010-01-15
CL2007001391A1 (es) 2008-01-18
PL2051975T3 (pl) 2013-01-31
KR20090017523A (ko) 2009-02-18
UY30352A1 (es) 2008-01-02
MX2008014499A (es) 2008-11-27
WO2007131982A3 (de) 2008-01-10
ECSP088824A (es) 2008-11-27
IL195245A0 (en) 2009-09-22
ES2395538T3 (es) 2013-02-13
NZ573573A (en) 2011-10-28
BRPI0711648A2 (pt) 2011-11-29
NO20084530L (no) 2008-12-12
JP2009537483A (ja) 2009-10-29
EA200802210A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
US7807693B2 (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
US8309542B2 (en) Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
WO2008135524A2 (en) Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
AU2006265216B2 (en) Substituted glycinamides having an antithrombotic and factor Xa-inhibiting effect
US8003639B2 (en) Substituted prolinamides, the preparation thereof and the use thereof as pharmaceutical compositions
WO2008135525A2 (en) Substituted azetidines, manufacturing and use thereof as medicaments
US20070032473A1 (en) Substituted amides and their use as medicaments
US8741890B2 (en) Substituted amides, manufacturing and use thereof as medicaments
HK1131140B (en) Substituted prolinamides, and the use thereof
CN101443326A (zh) 取代的脯氨酰胺、其制备方法及其作为药物的用途

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired